1
van Hulst, Marinus, Stevanovic, Jelena, Jacobs, Maartje S, Tieleman, Robert G, Kappelhoff, Bregt, Postma, Maarten J
Veröffentlicht in: van Hulst , M , Stevanovic , J , Jacobs , M S , Tieleman , R G , Kappelhoff , B & Postma , M J 2018 , ' The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands ' , Journal of Medical Economics , vol. 21 , no. 1 , pp. 38-46 . https://doi.org/10.1080/13696998.2017.1372222;
2018
Veröffentlicht in: van Hulst , M , Stevanovic , J , Jacobs , M S , Tieleman , R G , Kappelhoff , B & Postma , M J 2018 , ' The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands ' , Journal of Medical Economics , vol. 21 , no. 1 , pp. 38-46 . https://doi.org/10.1080/13696998.2017.1372222;
2018
2
van Hulst, Marinus, Tieleman, Robert G, Zwart, Lennaert A R, Pomp, Marc, Jacobs, Maartje S, Meeder, Joan G, van Ofwegen-Hanekamp, Clara E E, Hollander, Monika, Smits, Paul, Hemels, Martin E W
Veröffentlicht in: van Hulst , M , Tieleman , R G , Zwart , L A R , Pomp , M , Jacobs , M S , Meeder , J G , van Ofwegen-Hanekamp , C E E , Hollander , M , Smits , P & Hemels , M E W 2023 , ' Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands ' , European heart journal. Quality of care & clinical outcomes , vol. 9 , no. 4 , pp. 408-416 . https://doi.org/10.1093/ehjqcco/qcac042;
2023
Veröffentlicht in: van Hulst , M , Tieleman , R G , Zwart , L A R , Pomp , M , Jacobs , M S , Meeder , J G , van Ofwegen-Hanekamp , C E E , Hollander , M , Smits , P & Hemels , M E W 2023 , ' Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands ' , European heart journal. Quality of care & clinical outcomes , vol. 9 , no. 4 , pp. 408-416 . https://doi.org/10.1093/ehjqcco/qcac042;
2023